DaShenLin Pharmaceutical Group Co., Ltd. (SHA:603233)

China flag China · Delayed Price · Currency is CNY
17.77
+0.70 (4.10%)
Apr 22, 2025, 10:45 AM CST
-20.39%
Market Cap 19.41B
Revenue (ttm) 26.54B
Net Income (ttm) 850.26M
Shares Out 1.14B
EPS (ttm) 0.75
PE Ratio 22.76
Forward PE 18.60
Dividend 0.62 (3.63%)
Ex-Dividend Date Oct 23, 2024
Volume 5,681,281
Average Volume 8,851,873
Open 17.05
Previous Close 17.07
Day's Range 17.01 - 17.90
52-Week Range 11.92 - 23.26
Beta 0.60
RSI 58.42
Earnings Date Apr 29, 2025

About SHA:603233

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 45,466
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2023, SHA:603233's revenue was 24.53 billion, an increase of 15.45% compared to the previous year's 21.25 billion. Earnings were 1.17 billion, an increase of 12.63%.

Financial Statements

News

There is no news available yet.